CuraScientific Corp (CSTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -253.71 Thousand | -553.77 Thousand | -433.38 Thousand | 1299.00 | 11.7 Thousand | -24.4 Thousand |
| Net Income | -5.26 Million | -5.87 Million | -4.86 Million | -10.66 Thousand | -796.00 | 25.38 Thousand |
| Depreciation & Amortization | 616.26 Thousand | 611.35 Thousand | 386 Thousand | 11 Thousand | 11 Thousand | - |
| Deferred income taxes | 1.9 Million | -1.95 Million | 2.03 Million | - | - | - |
| Stock-based compensation | 475 Thousand | 3.3 Million | 1.6 Million | - | - | - |
| Change in working capital | 723.69 Thousand | 434.09 Thousand | 158.58 Thousand | 280.96 Thousand | 1500.00 | -49.78 Thousand |
| Other non-cash items | 1.29 Million | 2.92 Million | 248.56 Thousand | -258 Thousand | 73.24 Thousand | 45.18 Thousand |
| Investing Cash Flow | -14.91 Thousand | -5614.00 | - | - | - | - |
| Investments in PPE | -14.91 Thousand | -5614.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 245.39 Thousand | 575.55 Thousand | 438.14 Thousand | -2896.00 | -9375.00 | 25.44 Thousand |
| Debt repayment | -245.39 Thousand | -607 Thousand | -125 Thousand | - | - | -27.35 Thousand |
| Dividends payments | - | - | - | -3896.00 | -14.87 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | -1915.00 |
| Common Stock Issuance | - | - | - | 1000.00 | 5500.00 | - |
| Other Financing Activities | 490.78 Thousand | 1.18 Million | 563.14 Thousand | 264.6 Thousand | - | - |
| Accounts receivables | 36.69 Thousand | -16.69 Thousand | - | - | -28.54 Thousand | -3760.00 |
| Accounts payables | 197.19 Thousand | -23.19 Thousand | 136.49 Thousand | - | - | - |
| Inventory | 8403.00 | -1514.00 | -6889.00 | - | -22.7 Thousand | -41.42 Thousand |
| Other working capital | 481.4 Thousand | 475.49 Thousand | 28.98 Thousand | 280.96 Thousand | 1500.00 | -4603.00 |
| Cash at beginning of period | 23.36 Thousand | 7192.00 | 2439.00 | 4036.00 | 1034.00 | - |
| Cash at end of period | 130.00 | 23.36 Thousand | 7192.00 | 2439.00 | 4036.00 | 1034.00 |
| Capital Expenditure | -14.91 Thousand | -5614.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -23.23 Thousand | 16.16 Thousand | 4753.00 | -1597.00 | 3002.00 | 1034.00 |
| Free Cash Flow | -268.62 Thousand | -559.38 Thousand | -433.38 Thousand | 1299.00 | 11.7 Thousand | -24.4 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.71 Million | 41.28 Million | -216.26 Thousand | -1.65 Million | -5.26 Million | 194.12 Thousand |
| Depreciation & Amortization | 9388.00 | 4701.00 | 153.75 Thousand | 154.25 Thousand | 616.26 Thousand | 154.25 Thousand |
| Deferred income taxes | 235.71 Thousand | 1.49 Million | - | 668.64 Thousand | 1.9 Million | 880.18 Thousand |
| Stock-based compensation | -66 Thousand | 600 Thousand | - | 100 Thousand | 475 Thousand | 85 Thousand |
| Change in working capital | 126.62 Thousand | 159.07 Thousand | 151.75 Thousand | 101.99 Thousand | 723.69 Thousand | 243.62 Thousand |
| Other non-cash items | 5.15 Million | -43.59 Million | -88.87 Thousand | 633.46 Thousand | 1.29 Million | -1.55 Million |
| Investing Cash Flow | -97.68 Thousand | 76.73 Thousand | - | - | -14.91 Thousand | - |
| Investments in PPE | -97.68 Thousand | - | - | - | -14.91 Thousand | - |
| Acquisitions | 126.73 Thousand | 76.73 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -126.73 Thousand | 1.00 | - | - | - | - |
| Financing Cash Flow | 111.8 Thousand | 254.18 Thousand | - | - | 245.39 Thousand | - |
| Debt repayment | -111.8 Thousand | -254.18 Thousand | - | - | -245.39 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 223.6 Thousand | 508.37 Thousand | - | - | 490.78 Thousand | - |
| Accounts receivables | -1868.00 | - | - | 20 Thousand | 36.69 Thousand | 3240.00 |
| Accounts payables | 203.49 Thousand | 21.5 Thousand | 56.8 Thousand | 21.96 Thousand | 197.19 Thousand | 77.44 Thousand |
| Inventory | 7158.00 | 49.58 Thousand | - | 13.68 Thousand | 8403.00 | 20.00 |
| Other working capital | -82.16 Thousand | 87.98 Thousand | 94.94 Thousand | 46.34 Thousand | 481.4 Thousand | 162.91 Thousand |
| Cash at beginning of period | 281.72 Thousand | 502.00 | 130.00 | 176.00 | 23.36 Thousand | 689.00 |
| Cash at end of period | 40.91 Thousand | 281.72 Thousand | 502.00 | 130.00 | 130.00 | 176.00 |
| Capital Expenditure | -97.68 Thousand | - | - | - | -14.91 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -240.81 Thousand | 281.22 Thousand | 372.00 | -46.00 | -23.23 Thousand | -513.00 |
| Free Cash Flow | -352.61 Thousand | -49.69 Thousand | 372.00 | -46.00 | -268.62 Thousand | -513.00 |
APAX
000682
7886
002360
3666
PLUR